About us
Our team
Our science
Radiopharmaceuticals
Our technology
Abstracts & publications
Our pipeline
News
All news
ASX releases
Media releases
Events and presentations
Investors
Investor hub
ASX announcements
Annual reports
Investor presentations
Corporate governance
Corporate policies
Contact us
About us
Our team
Our science
Radiopharmaceuticals
Our technology
Abstracts & publications
Our pipeline
News
Investors
Investor hub
ASX announcements
Annual reports
Investor presentations
Corporate governance
Corporate policies
Contact us
Innovating the way we see and treat cancer
Innovating the way we see and treat cancer
VIDEO
Radiopharm Theranostics panel discusses latest progress and understanding of radiopharmaceutical sector
PLAY
LATEST NEWS
Sign up to Investor Hub to get all the latest news and ASX Announcements direct to your inbox
Sign up
We are focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need.
Our technology
The unique potential of Radiopharmaceuticals in treating oncological diseases.
Learn more
Our pipeline
The unique potential of being
First to Market
or
Best in Class.
Learn more
Our team
We have a unique commitment to improve patients’ hope in fighting cancer.
Learn more
Information for investors
Stock price, Company governance & updates from our multiple development programs.
Learn more
Latest news
Media Coverage
November 12, 2021
Radiopharm Theranostics’ Founder Paul Hopper’s keynote address at Emerging Small Caps 2021 Summit
Read more
Read more
ASX Releases
October 13, 2021
Radiopharm Theranostics’ Trivehexin (AVβ6-Integrin) published in European Journal of Nuclear Medicine
Read more
Read more
Sign up to our mailing list.
Receive all the latest news from Radiopharm Theranostics.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form. Please fill out all starred fields.